Jaclyn Wall

Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer

Ilaria Betella, William J. Turbitt, Tomasz Szul et al. · Gynecologic Oncology · 2020 · 60 citations

Modulator Dkk1, Signaling Pathway, Medicine +8

Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy

Jaclyn Wall, Selene Meza‐Perez, Carly Bess Scalise et al. · Gynecologic Oncology · 2020 · 50 citations · Full text

Signaling Pathway, Medicine, Anti-tumor Immune Infiltration +8

Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment

Whitney N. Goldsberry, Selene Meza‐Perez, Angelina I. Londoño et al. · Cancers · 2020 · 27 citations · Full text

Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect

Rebecca C. Arend, Hannah Beer, Yaël C. Cohen et al. · Gynecologic Oncology · 2020 · 22 citations · Full text

Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study

Rebecca C. Arend, Nidhi Goel, B.M. Roane et al. · Gynecologic Oncology · 2021 · 14 citations

Sequencing, Oncology, Uterine Cancer +11